The CIR tax accreditation has provided Symbiosis with a strong basis to working with French companies and allows eligible companies to benefit from significant tax relief (Crédit d’Impôt de Recherche) on R&D activities carried out by Symbiosis on their behalf. You can find a link to our approval on the French governments’ website here:http://www.enseignementsup-recherche.gouv.fr/cid23182/cir-liste-des-organismes-experts-bureaux-de-style-et-stylistes-agrees.html
Symbiosis would like to expand its work with French companies, to assist in developing drug projects, for clinical trials and niche commercial markets. If you have any other questions or you would like to discuss any potential projects with an expert in the sterile drug manufacturing field then please send an email to firstname.lastname@example.org or call 44 (0)1786 220 000.
We look forward to hearing from you soon.
Symbiosis Pharmaceutical Services is a world class specialist in the manufacturing of sterile injectable drugs for clinical trials and niche commercial marketed products. Our aim is to successfully reduce our clients’ drug development times.